Iterum Therapeutics Future Growth

How is Iterum Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

2/6

Future Growth Score 2/6

-3.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqCM:ITRM - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	5	-78	N/A	N/A	1
12/31/2024	N/A	-64	N/A	N/A	1
12/31/2023	N/A	-74	N/A	N/A	1
9/30/2022	N/A	-44	-17	-17	N/A
6/30/2022	N/A	-11	-16	-16	N/A
3/31/2022	N/A	4	-18	-18	N/A
12/31/2021	N/A	-92	-16	-16	N/A
9/30/2021	N/A	-99	-22	-22	N/A
6/30/2021	N/A	-115	-23	-23	N/A
3/31/2021	N/A	-135	-28	-28	N/A
12/31/2020	N/A	-52	-55	-55	N/A
9/30/2020	N/A	-64	-69	-69	N/A
6/30/2020	N/A	-84	-90	-90	N/A
3/31/2020	N/A	-99	-94	-94	N/A
12/31/2019	0	-103	-82	-82	N/A
9/30/2019	0	-104	-83	-83	N/A
6/30/2019	1	-97	-85	-85	N/A
3/31/2019	1	-85	-79	-79	N/A
12/31/2018	1	-77	-77	-77	N/A
9/30/2018	1	-62	-62	-62	N/A
6/30/2018	1	-45	-40	-40	N/A
3/31/2018	1	-36	-37	-37	N/A
12/31/2017	1	-29	-31	-31	N/A

Earnings vs Savings Rate: ITRM is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ITRM is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ITRM is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ITRM's revenue (75.6% per year) is forecast to grow faster than the US market (7.2% per year).

High Growth Revenue: ITRM's revenue (75.6% per year) is forecast to grow faster than 20% per year.

Future ROE: Insufficient data to determine if ITRM's Return on Equity is forecast to be high in 3 years time